Microtubules and resistance to tubulin-binding agents M Kavallaris Nature Reviews Cancer 10 (3), 194-204, 2010 | 1283 | 2010 |
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. M Kavallaris, DY Kuo, CA Burkhart, DL Regl, MD Norris, M Haber, ... The Journal of clinical investigation 100 (5), 1282-1293, 1997 | 781 | 1997 |
Metronomic chemotherapy: new rationale for new directions E Pasquier, M Kavallaris, N André Nature reviews Clinical oncology 7 (8), 455-465, 2010 | 739 | 2010 |
Movers and shakers: cell cytoskeleton in cancer metastasis CM Fife, JA McCarroll, M Kavallaris British journal of pharmacology 171 (24), 5507-5523, 2014 | 565 | 2014 |
Minimum information reporting in bio–nano experimental literature M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ... Nature nanotechnology 13 (9), 777-785, 2018 | 559 | 2018 |
Biologically targeted magnetic hyperthermia: Potential and limitations D Chang, M Lim, JACM Goos, R Qiao, YY Ng, FM Mansfeld, M Jackson, ... Frontiers in pharmacology 9, 831, 2018 | 493 | 2018 |
Microtubules and their role in cellular stress in cancer AL Parker, M Kavallaris, JA McCarroll Frontiers in oncology 4, 153, 2014 | 457 | 2014 |
Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells KM Murphy, V Ranganathan, ML Farnsworth, M Kavallaris, RB Lock Cell Death & Differentiation 7 (1), 102-111, 2000 | 424 | 2000 |
Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non–small cell lung cancer PP Gan, E Pasquier, M Kavallaris Cancer research 67 (19), 9356-9363, 2007 | 310 | 2007 |
The role of β-tubulin isotypes in resistance to antimitotic drugs CA Burkhart, M Kavallaris, SB Horwitz Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1471 (2), O1-O9, 2001 | 295 | 2001 |
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells M Kavallaris, AS Tait, BJ Walsh, L He, SB Horwitz, MD Norris, M Haber Cancer research 61 (15), 5803-5809, 2001 | 290 | 2001 |
Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood R Tavallaie, J McCarroll, M Le Grand, N Ariotti, W Schuhmann, E Bakker, ... Nature nanotechnology 13 (11), 1066-1071, 2018 | 267 | 2018 |
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment E Pasquier, J Ciccolini, M Carre, S Giacometti, R Fanciullino, C Pouchy, ... Oncotarget 2 (10), 797, 2011 | 264 | 2011 |
Microtubules: a dynamic target in cancer therapy E Pasquier, M Kavallaris IUBMB life 60 (3), 165-170, 2008 | 264 | 2008 |
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol M Kavallaris, CA Burkhart, SB Horwitz British journal of cancer 80 (7), 1020-1025, 1999 | 256 | 1999 |
Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ... Cancer research 80 (19), 4129-4144, 2020 | 248 | 2020 |
Acid-labile core cross-linked micelles for pH-triggered release of antitumor drugs Y Chan, T Wong, F Byrne, M Kavallaris, V Bulmus Biomacromolecules 9 (7), 1826-1836, 2008 | 219 | 2008 |
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β‐tubulins S Tommasi, A Mangia, R Lacalamita, A Bellizzi, V Fedele, A Chiriatti, ... International journal of cancer 120 (10), 2078-2085, 2007 | 215 | 2007 |
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer JA McCarroll, S Naim, G Sharbeen, J Lee, M Kavallaris, D Goldstein, ... Frontiers in physiology 5, 141, 2014 | 190 | 2014 |
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma E Pasquier, J Street, C Pouchy, M Carre, AJ Gifford, J Murray, MD Norris, ... British journal of cancer 108 (12), 2485-2494, 2013 | 186 | 2013 |